Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2012
05/23/2012EP1789067B1 Use of growth hormone secretagogues for stimulating the motility of the gastrointestinal system
05/23/2012EP1781780B1 Treating cancer
05/23/2012EP1761248B1 Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds
05/23/2012EP1663283B1 Glutamine for use in treating injury
05/23/2012EP1660057B1 Combination therapy for the treatment of ocular neovascular disorders
05/23/2012EP1567641B1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
05/23/2012EP1548435B1 Diagnostic method for eating disorders
05/23/2012EP1509610B1 Transgenic plants with controlled distribution of a trait to progeny
05/23/2012EP1446418B1 Integrin targeting compounds
05/23/2012EP1346059B1 Photochemical internalization for delivery of molecules into the cytosol
05/23/2012CN1964733B Novel use of peptide compounds for treating essential tremor
05/23/2012CN1950102B Modulation of cartilage homeostasis
05/23/2012CN1659288B Pharmaceutical composition for preventing or reducing DNA damage
05/23/2012CN1653086B Novel peptide compositions and the use thereof in the preparation of active pharmaceutical compositions against the hepatitis C virus
05/23/2012CN102471770A Antigen peptide and use thereof
05/23/2012CN102471765A Neurotoxins exhibiting shortened biological activity
05/23/2012CN102471371A 用于肿瘤血管系统的归巢肽 Homing peptides for tumor vasculature
05/23/2012CN102471369A 肽类化合物及其用途 Peptide compounds and their uses
05/23/2012CN102470182A 用于在出血性紊乱的治疗和预防性处理中进行非静脉内施用的白蛋白融合凝血因子 Albumin is used for non-intravenous administration in the treatment of bleeding disorders and the prophylactic treatment of coagulation factor fusion
05/23/2012CN102470166A Dipeptidyl peptidase-4 inhibitor
05/23/2012CN102470165A Preparation comprising insulin, nicotinamide and an amino acid
05/23/2012CN102470164A 以每周给药1次每次为100单位~200单位的pth为特征的、含有pth的骨质疏松症治疗/预防剂 Is administered once per week for every 100 units to 200 units pth characterized, osteoporosis containing pth / prophylactic agent for
05/23/2012CN102470163A Composition for external preparation for skin
05/23/2012CN102470162A 用于治疗难治性c型慢性肝炎的药剂以及方法 The treatment of refractory chronic hepatitis c agents and methods for
05/23/2012CN102470161A 神经调节蛋白用于治疗心力衰竭的有效剂量 Neuregulin effective dose for the treatment of heart failure
05/23/2012CN102470160A 抑制肌肉收缩的化合物 Compounds inhibiting muscle contraction
05/23/2012CN102470159A Composition for the treatment of benign prostate hyperplasia
05/23/2012CN102470158A 制备丙型肝炎病毒的蛋白酶抑制剂的工艺方法 A process for preparing a hepatitis C virus protease inhibitors
05/23/2012CN102470157A 广谱erbb配体结合分子及其制备和使用方法 Erbb broad spectrum ligand-binding molecules and methods for preparing and using
05/23/2012CN102470156A 选择性作用于αvβ3整合素并缀合人血清白蛋白(HSA)变体的多肽及其药学用途 Selective effect on αvβ3 integrin and conjugated polypeptides and pharmaceutical use of human serum albumin (HSA) variant
05/23/2012CN102470150A 包含肺表面活性物质和抗氧化酶的治疗组合物 Contains pulmonary surfactant and antioxidant enzyme therapeutic compositions
05/23/2012CN102470116A Use of the combination of teriflunomide and interferon beta for treating multiple sclerosis
05/23/2012CN102470106A Composition comprising oil drops
05/23/2012CN102465146A 融合表达重组制备t4核酸内切酶v Recombinant fusion protein was prepared t4 endonuclease v
05/23/2012CN102464712A 缺失型人成纤维细胞生长因子21变异体及其偶联物 Deficient human fibroblast growth factor-21 variants and their conjugates
05/23/2012CN102464705A 白念珠菌致病相关基因sfl2及其用途 Candida albicans virulence-related genes and their use sfl2
05/23/2012CN102464704A Novel compound, its preparation method and application
05/23/2012CN102464702A 制备醋酸亮丙瑞林的方法、产品及用途 Leuprolide preparation methods, products and uses
05/23/2012CN102464701A New type compound, its preparation method and application
05/23/2012CN102464654A 新型抗病毒化合物 Novel antiviral compounds
05/23/2012CN102462837A Anti-inflammatory composition
05/23/2012CN102462668A Hydrochloric acid boningmycin solid preparation and preparation method thereof
05/23/2012CN102462662A 脂质体包裹重组人睫状神经营养因子 Liposome-encapsulated recombinant human ciliary neurotrophic factor
05/23/2012CN102462661A 一种抗菌肽脂质体的制备方法 A method of preparing liposomes antimicrobial peptides
05/23/2012CN102229658B Anti-rheumatoid arthritis polypeptide and its application in pharmacy
05/23/2012CN102229657B Polypeptide against rheumatoid arthritis and application thereof in pharmacy
05/23/2012CN102229656B Polypeptide against rheumatoid arthritis and application thereof in pharmacy
05/23/2012CN102229655B Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
05/23/2012CN102229654B Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
05/23/2012CN102229653B Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
05/23/2012CN102229652B Polypeptide against rheumatoid arthritis and application thereof in pharmacy
05/23/2012CN102028661B Pegylated recombinant human granulocyte colony stimulating factor freeze-dried powder/injection and preparation method thereof
05/23/2012CN102018952B Tablet for nourishing liver, protecting liver, sobering up and strengthening kidney and preparation process thereof
05/23/2012CN102000121B Cordyceps militaris oligopeptide composition as well as preparation method and use thereof
05/23/2012CN101979572B Preparation for South China Sea conus striatus toxin S4.3 and application
05/23/2012CN101928709B Gene sequence, recombinant expression and application of hyalomma asiaticum histamine binding protein (HaHBP)
05/23/2012CN101926980B Application of cytotoxin (CTX1) from snake venom to preparation of medicament for rehabilitating
05/23/2012CN101906143B Conjugate of two Arg-Gly-Asp chains and one fatty alcohol chain through Lys, synthesis and medicine application thereof
05/23/2012CN101899090B Saturated fatty chain alcohol His-Gly-AA tripeptide ester, synthetic method and application thereof
05/23/2012CN101899087B Saturated fatty chain amine Glu-Asp-Gly tripeptide amides as well as synthesis method and application thereof
05/23/2012CN101899086B Saturated fatty chain acid Glu-Asp-Gly tripeptide amide, synthetic method and application thereof
05/23/2012CN101892239B Schistosoma japonicum katsurada Frizzled 9 gene, protein and use
05/23/2012CN101829320B Collagen gel and preparation method thereof
05/23/2012CN101816634B Technology for preparing bone growth factor carrying microsphere by using ultrasonic atomization method
05/23/2012CN101804197B Medicament compound for treating cancer bone metastasis and purposes thereof
05/23/2012CN101787117B Preparation method and application of polyethylene glycol-polysialic acid block copolymers
05/23/2012CN101775400B Rana chensinensis functional gene Rd-RNase2 sequence, construction method and amino acid sequence and application thereof
05/23/2012CN101698682B Double-functional fusion protein based on antibacterial peptide, preparation method and applicaitoin thereof
05/23/2012CN101688193B Modified phosphatases
05/23/2012CN101670095B Pharmaceutical composition for treating embolism and preparation method thereof
05/23/2012CN101648010B Preparation for promoting fibroblasts to secrete extracellular matrix components and preparation method thereof
05/23/2012CN101648009B Method for preparing cordycepin SOD medicinal granules
05/23/2012CN101643722B Low molecular weight EC-SOD recombinant enzyme, preparation method and usage thereof
05/23/2012CN101633947B New method for preparing sunflower seed meal proteolytic peptide and application of sunflower seed meal proteolytic peptide
05/23/2012CN101560510B Agkistrodon acutus hemocoagulase atrox
05/23/2012CN101519426B Lactalbumin polypeptide with antioxidation activity and preparation method thereof
05/23/2012CN101429251B Antineoplastic amalgamation protein, preparation method and uses thereof
05/23/2012CN101407539B Oligopeptide having marrow hemopoiesis protection function, preparation thereof, pharmaceutical composition containing the oligopeptide and use
05/23/2012CN101361962B New use of thymosin alpha1
05/23/2012CN101353668B Mouse beta-alexin 1 recombinant plasmids, polypeptides, uses and preparations thereof
05/23/2012CN101343327B Antiviral protein and uses thereof
05/23/2012CN101323640B Enzymolysis product inhibiting alpha-glucosidase activity and use thereof
05/23/2012CN101270359B Method for preparing recombined human amyloid A beta 42 and application thereof
05/23/2012CN101235083B HIV-I resisting polypeptide, coded sequence and use thereof
05/23/2012CN101141975B Vegf拮抗剂制剂 Vegf antagonist preparations
05/23/2012CN101089178B Beta-lactamase and its prepn process and application
05/23/2012CN101087805B Method for purifying FSH
05/22/2012US8183363 Antisense oligonucleotide modulation of STAT3 expression
05/22/2012US8183362 Method and medicament for inhibiting the expression of a given gene
05/22/2012US8183361 Oligonucleotide-containing pharmacological compositions and their use
05/22/2012US8183354 Virus coat protein/receptor chimeras and methods of use
05/22/2012US8183352 Attenuated vif DNA immunization cassettes for genetic vaccines
05/22/2012US8183350 Compositions and methods for promoting neuronal outgrowth
05/22/2012US8183345 Recombinant factor VIII having reduced inactivation by activated protein C
05/22/2012US8183344 Inactivation resistant factor VIII
05/22/2012US8183343 Methods for treating a skin wound
05/22/2012US8183341 Antibacterial compounds and processes for its production
05/22/2012US8183340 GLP-1 pegylated compounds
05/22/2012US8183339 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
05/22/2012US8183231 Substituted propane phosphinic acid derivatives